Linagliptin Impurity 70 - Request Quote
Linagliptin Impurity 70
| SZ CAT No: | SZ-L024106 |
| CAS No | NA |
| Mol.F. | C26H29N7O2 |
| Mol.Wt. | 471.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Linagliptin Impurity 70 is chemically 2-((S)-3-Aminopiperidin-1-yl)-1-((S)-buta-1,2-dien-1-yl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1,4-dihydro-5H-imidazo[4,5-b]pyridine-5,7(6H)-dione. Linagliptin Impurity 70 is supplied with detailed characterization data compliant with regulatory guideline. Linagliptin Impurity 70 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linagliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Linagliptin Impurity 70
Purchase Linagliptin Impurity 70
Linagliptin Impurity 70 suppliers
Linagliptin Impurity 70 manufacturers
Linagliptin Impurity 70 price
Order Linagliptin Impurity 70
Enquire Linagliptin Impurity 70
Linagliptin Impurity 70 cost
Linagliptin Impurity 70 Supplier
Linagliptin Impurity 70 Distributor
Linagliptin Impurity 70 for Method Validation
Linagliptin Reference Standard
Linagliptin Impurity 70 for ANDA Filing
Linagliptin Impurity 70 for Forced Degradation Studies
Linagliptin Impurity 70 Identification Standards
Linagliptin Impurity 70 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.